Is post‑embolization syndrome common after uterine artery embolization (UAE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Embolization Syndrome After UAE

Yes, post-embolization syndrome is common after uterine artery embolization, occurring in approximately 48% of patients. 1, 2

What is Post-Embolization Syndrome?

Post-embolization syndrome is a flu-like syndrome characterized by pain, nausea, fever, and leukocytosis that occurs following UAE 1. This is a recognized and expected side effect of the procedure, not a complication requiring intervention in most cases.

Incidence and Clinical Significance

The most recent data from 2025 shows that clinically significant post-embolization syndrome (defined as pain score >5/10 plus morphine use >10mg, fever, or requiring ≥2 antiemetics) occurred in 47.8% of patients 2. Earlier meta-analysis data reported rates of 2.86% in randomized trials and 3.37% for discharge and fever in non-randomized studies 3, though these likely represent more severe presentations requiring hospitalization.

Risk Factors to Identify

Nulliparity is strongly associated with developing clinically significant post-embolization syndrome (OR: 5.51,95% CI: 1.297-23.410) 2. Additionally:

  • Increasing age appears protective, with a trend toward reduced odds of developing the syndrome (OR: 0.87 per year increase) 2
  • Larger fibroid diameter (for each 25mm increase) increases risk of both early and late complications (OR: 1.7 for early, 1.5 for late) 4
  • Multiple fibroids increase risk of early complications (OR: 3.7) 4

Clinical Management Approach

Pre-procedure Counseling

Inform nulliparous patients and those with large or multiple fibroids that they face higher risk of post-embolization syndrome. Set expectations that nearly half of patients will experience these symptoms.

Prophylaxis

Dexamethasone-based prophylactic therapy significantly reduces all components of post-embolization syndrome 5:

  • Pain reduction: RR 0.58
  • Fever reduction: RR 0.36
  • Nausea reduction: RR 0.52
  • Vomiting reduction: RR 0.54

Optimal dosing is 6-12mg divided throughout the perioperative period (not just preoperatively), with postoperative and continuous administration more effective than preoperative alone 5.

Critical Pitfall: Distinguishing from Serious Complications

Do not assume all fever and pain post-UAE is benign post-embolization syndrome. Watch for:

  • Persistent high-grade fever beyond 2 weeks despite antibiotics suggests pyomyoma or uterine necrosis 6, 7
  • Intralesional gas on imaging indicates pyomyoma requiring source control with hysterectomy 6
  • Persistent symptoms beyond typical post-procedural course warrant contrast-enhanced CT or MRI to exclude uterine ischemia/necrosis 7

Post-embolization syndrome typically resolves within days to weeks. Symptoms persisting beyond this timeframe require imaging evaluation to exclude serious complications that occur in 1.4-2.7% of cases 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.